New Drugs to Treat Duchenne Muscular Dystrophy
Reviving a gene which is “turned down” after birth is potentially the key to treating Duchenne Muscular Dystrophy, an untreatable muscle-wasting condition which affects one in every 3,500 boys.
Immunotec Oxford Raises $64m in Nasdaq IPO
Oxford Immunotec – a 2002 Isis spin-out – has raised US$64 million in an IPO on America’s Nasdaq stock exchange. The Abingdon-based company sells diagnostic tests for latent tuberculosis infection, T-SPOT®.TB.
Eykona Technologies Ltd Raises £1.19m
Oxford University Innovation Ltd. welcomes the announcement by Eykona, an Oxford-based medical technology company, that it has completed an investment round of £1.19m. The round, which was over-subscribed, allows Eykona to progress its innovative 3D wound imaging system to launch and beyond.
Oxitec Limited Wins TSB Funding
Based on technology developed by molecular biologist Dr Luke Alphey and colleagues at Oxford University's Department of Zoology, Oxitec was spun-out of Oxford University Innovation in 2002.
Stories of Success
“From bright sparks to brilliant businesses” is a newly published book by Sir Douglas Hague and Anthea Milnes profiling University of Oxford spin-outs.
Isis Participates in New Start-up Company Developing Novel Medicines
Oxford University Innovation Ltd, the technology transfer company of the University of Oxford, is pleased to announce its participation in the formation of IXO Therapeutics Ltd, a new biotechnology company formed to research and develop novel medicines from natural sources for the treatment of immune-mediated and inflammatory diseases, which launches today.
Cheaper Solar Technology Developed in Oxford
Oxford, UK: Oxford Photovoltaics, a company recently spun out from the University of Oxford by Oxford University Innovation Ltd., has developed new solar cell technology that is manufactured from cheap, abundant, non-toxic and non-corrosive materials and can be scaled to any volume.
Oxford University spinout crysalin successfully completes £1.55m funding round
A £1.55m fundraising round has been successfully completed by Crysalin Limited, a company founded as a spinout from the University of Oxford Biochemistry Department by Oxford University Innovation Limited.
Oxford Spinout OXEMS Wins Prestigious Award
Oxford Electromagnetic Solutions Limited (OXEMS), which was spun out of the Department of Engineering Science of Oxford University by Oxford University Innovation in July 2010, has won a ‘Discovering Start-Ups 2010’ award, demonstrating that its new approach to detecting buried utility assets is recognised as an exciting innovation with great commercial potential.
Oxford spin-out OrganOx raises new funding
OrganOx Ltd, spun-out of the University of Oxford by Oxford University Innovation Ltd in 2008, has completed a Series B investment round of £2.75m. The round, which was over-subscribed, was supported by existing shareholders and a number of new ones, including the Royal Society.
© Oxford University Innovation